Revenue, 2025
USD 3.07 Bn
Forecast Year, 2034
USD 5.23 Bn
CAGR, 2025 - 2034
6.07%
Report Coverage
Worldwide
The global Gabapentin market, valued at USD 3.07 billion in 2025, is projected to reach USD 5.23 billion by 2034, growing at a CAGR of 6.07%, driven by rising demand for neuropathic pain management and neurological disorder treatments.
Gabapentin Market Size Analysis
Gabapentin Market Size By Dosage 2025 to 2034 (USD Billion)
| Dosage | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Tablet | 1.45 | 1.54 | 1.63 | 1.73 | 1.84 | 1.95 | 2.07 | 2.19 | 2.33 | 2.47 |
| Capsule | 1.05 | 1.11 | 1.18 | 1.25 | 1.33 | 1.41 | 1.50 | 1.59 | 1.68 | 1.78 |
| Oral Solution | 0.57 | 0.60 | 0.64 | 0.68 | 0.72 | 0.76 | 0.81 | 0.86 | 0.91 | 0.96 |
Gabapentin Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Generic | 2.06 | 2.19 | 2.32 | 2.46 | 2.61 | 2.77 | 2.93 | 3.11 | 3.30 | 3.50 |
| Branded | 1.01 | 1.07 | 1.14 | 1.20 | 1.28 | 1.36 | 1.44 | 1.52 | 1.62 | 1.72 |
Gabapentin Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Epilepsy | 1.24 | 1.32 | 1.40 | 1.48 | 1.57 | 1.67 | 1.77 | 1.88 | 1.99 | 2.11 |
| Neuropathic Pain | 1.04 | 1.11 | 1.18 | 1.25 | 1.32 | 1.40 | 1.49 | 1.58 | 1.67 | 1.78 |
| Restless Legs Syndrome | 0.47 | 0.50 | 0.53 | 0.56 | 0.59 | 0.63 | 0.67 | 0.71 | 0.75 | 0.79 |
| Others | 0.32 | 0.33 | 0.35 | 0.38 | 0.40 | 0.42 | 0.45 | 0.48 | 0.51 | 0.54 |
Gabapentin Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 1.33 | 1.41 | 1.50 | 1.59 | 1.68 | 1.79 | 1.90 | 2.01 | 2.13 | 2.26 |
| Retail Pharmacy | 1.20 | 1.28 | 1.35 | 1.44 | 1.52 | 1.62 | 1.71 | 1.82 | 1.93 | 2.05 |
| Online Pharmacy | 0.54 | 0.57 | 0.60 | 0.64 | 0.68 | 0.72 | 0.76 | 0.81 | 0.86 | 0.91 |
Gabapentin Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.12 | 1.19 | 1.26 | 1.34 | 1.42 | 1.51 | 1.60 | 1.69 | 1.80 | 1.91 |
| Europe | 0.80 | 0.84 | 0.90 | 0.95 | 1.01 | 1.07 | 1.13 | 1.20 | 1.28 | 1.35 |
| Asia Pacific | 0.68 | 0.72 | 0.77 | 0.81 | 0.86 | 0.91 | 0.97 | 1.03 | 1.09 | 1.16 |
| Latin America | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 | 0.40 | 0.42 | 0.45 | 0.48 |
| Middle East and Africa | 0.19 | 0.20 | 0.21 | 0.23 | 0.24 | 0.25 | 0.27 | 0.29 | 0.30 | 0.32 |
Gabapentin Market Size to Lead USD 5.23 Billion by 2034
The global gabapentin market size was calculated at USD 3.07 billion in 2025 and is predicted to attain around USD 5.23 billion by 2034 a CAGR of 6.07%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com